Ensysce Biosciences (ENSC) Non-Current Assets (2017 - 2025)

Ensysce Biosciences (ENSC) has reported Non-Current Assets for 9 consecutive years, with $207461.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Non-Current Assets fell 17.85% year-over-year to $207461.0 in Q4 2025; TTM through Dec 2025 was $962398.0, a 23.63% decrease from a year earlier, with the FY2025 full-year figure at $207461.0, down 17.85% from the prior year.
• Non-Current Assets was $207461.0 for Q4 2025 at Ensysce Biosciences, down from $251194.0 in the prior quarter.
• Over five years, Non-Current Assets peaked at $12.8 million in Q1 2021 and troughed at -$7.9 million in Q3 2021.
• A 5-year average of $259784.4 and a median of $398383.5 in 2023 frame the typical range for Non-Current Assets.
• The widest YoY moves for Non-Current Assets: up 19100.1% in 2021, down 159.54% in 2021.
• Over 5 years, Non-Current Assets stood at $754756.0 in 2021, then retreated by 22.37% to $585883.0 in 2022, then dropped by 28.45% to $419217.0 in 2023, then sank by 39.76% to $252550.0 in 2024, then slipped by 17.85% to $207461.0 in 2025.
• The last three Non-Current Assets figures came in at $207461.0 (Q4 2025), $251194.0 (Q3 2025), and $292860.0 (Q2 2025), per Business Quant data.